Rachel Michaelson-Cohen, Director, Prenatal Genetics Unit, Medical Genetics Institute, Shaare Zedek Medical Center & Lecturer, Faculty of Medicine, Hebrew University 1995-2002: MD, Hebrew University 2003-2009: Residency, Gynecology, Shaare Zedek; 2009-2011: Fellowship, Medical Genetics, Shaare Zedek; 2017-2020: Public Health School, Faculty of Medicine, Hebrew University, MPH Cum laude Membership: European Society of Human Genetics; Israel Society of Medical Genetics Israel Hereditary Breast Ovarian Cancer Consortium American Society Human Genetic American College Medical Genetics International Consensus group: BRCA1/2 carriers following Salpingo-Oophorectomy Recent Awards: 2021: Joint Research Fund Hebrew University, Shaare Zedek: Ovarian cancer in BRCA carriers 2021: Austrian Breast Cancer Group, Department of Defense Grant, BRCA-Prevention trial. 2021-2022: Faculty of Medicine MPH award, Hebrew University 2022: Academic Excellence Award, Annual Research Conference, Shaare Zedek, 2022 The Israeli National Institute for Health Policy Research Fund. Tele-health genetic counseling Scientific Contributions related to BRCA: Initiation of specialized multidisciplinary clinics for BRCA mutation carriers; Collection of epidemiologic data on surveillance, intervention, and oncologic parameters; Thesis instruction of numerous MD students (one recently received honors); PI of 5 HBOC research projects and PI of RCT on breast cancer prevention in BRCA1 carriers.